Ogivri 420 mg pulver til koncentrat til infusionsvæske, opløsning
Active ingredient: nicht angegeben
View notice details →News topic
Product Ogivri
Current shortage notices for the product family Ogivri, structured by product, country and reporting period.
3 noticesOgivri 150 mg pulver til koncentrat til infusionsvæske, opløsning
Active ingredient: nicht angegeben
View notice details →Ogivri 420 mg pulver til koncentrat til infusionsvæske, opløsning
Active ingredient: Trastuzumab
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →